European Global Times
SEE OTHER BRANDS

The most trusted news from Europe

European Global Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.

Press releases published on May 6, 2025

Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update

Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update

Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development …

NuCana Prices $7 Million Registered Direct Offering

NuCana Prices $7 Million Registered Direct Offering

EDINBURGH, United Kingdom, May 06, 2025 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA), a clinical-stage biopharmaceutical company that focuses on significantly improving treatment outcomes for patients with cancer, announced that it has priced a registered …

Digital Marketplace Eneba Hits 100,000 Products Milestone, Continues Expansion

Digital Marketplace Eneba Hits 100,000 Products Milestone, Continues Expansion

LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Leading digital entertainment marketplace Eneba has zoomed past a major milestone, surpassing 100,000 products in its ever-growing catalog. Since its 2018 launch, the digital platform has evolved into a gaming …

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …

Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy

Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy

Ingelheim, Germany, May 6, 2025 – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for geographic atrophy (GA).[1 …

ReportAId raises €2.2M using AI to unlock healthcare data

ReportAId raises €2.2M using AI to unlock healthcare data

Milan, May 06, 2025 (GLOBE NEWSWIRE) -- Ask any doctor what's keeping them from delivering better care, and paperwork will top the list. Despite billions invested in healthcare technology, 80% of clinical data remains trapped in unstructured reports, and …

Changes in Nokia Corporation's own shares

Changes in Nokia Corporation's own shares

Nokia Corporation Stock Exchange Release 6 May 2025 at 15:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 139 888 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's …

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Muutokset Nokia Oyj:n omien osakkeiden omistuksessa

Nokia Oyj Pörssitiedote 6.5.2025 klo 15.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 139 888 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David …

Avalyn Announces Multiple Presentations on AP01 and AP02 for Pulmonary Fibrosis at the American Thoracic Society 2025 International Conference

Avalyn Announces Multiple Presentations on AP01 and AP02 for Pulmonary Fibrosis at the American Thoracic Society 2025 International Conference

Topline Results from the AP02 (Inhaled Nintedanib) Phase 1 Clinical Trials Among the Company’s Five Poster Presentations 4.5 Year Long-Term Safety and Efficacy Data Supporting AP01 (Inhaled Pirfenidone) from the ATLAS Open-Label Extension Trial to be …

Quoin Pharmaceuticals to Announce First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Quoin Pharmaceuticals to Announce First Quarter 2025 Financial Results on Tuesday, May 13, 2025

ASHBURN, Va., May 06, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its …

Cogent Biosciences Reports First Quarter 2025 Financial Results

Cogent Biosciences Reports First Quarter 2025 Financial Results

Three Registration-Directed Top-line Data Readouts Remain on Track in 2025: SUMMIT in NonAdvanced SM expected in July, APEX in Advanced SM expected in second half of the-year and PEAK in GIST expected by end of year Ended 1Q 2025 with $245.7 million in …

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, …

Vital Battery Metals Appoints Michael Mulberry as Advisor

Vital Battery Metals Appoints Michael Mulberry as Advisor

VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | OTC: VBAMF | FRA: C0O), is pleased to announce the appointment of Michael Mulberry as a technical advisor to the Company (the “ …

Trident Resources Receives Drill Permits for its High-Grade Gold Projects Located in Saskatchewan; Plans for Upcoming Drill Programs

Trident Resources Receives Drill Permits for its High-Grade Gold Projects Located in Saskatchewan; Plans for Upcoming Drill Programs

Vancouver, BC, May 06, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSXV: ROCK) (OTCQB: EROSD) (“Trident” or the “Company”) is pleased to announce that the Saskatchewan Ministry of Environment has issued two exploration permits for the Contact Lake …

VAXIL: SHARE CONSOLIDATION

VAXIL: SHARE CONSOLIDATION

Not for distribution by US newswire or in United States TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), is pleased to make the following updates regarding the Company’s activities. Vaxil announces …

Best Payday Loans Online: Top 5 Best Payday Loans Online and No Credit Check Loans Guaranteed Approval Alternatives for Bad Credit - Payday Ventures

Best Payday Loans Online: Top 5 Best Payday Loans Online and No Credit Check Loans Guaranteed Approval Alternatives for Bad Credit - Payday Ventures

LONDON, May 06, 2025 (GLOBE NEWSWIRE) -- Need fast cash before your next paycheck? Whether you're dealing with an emergency or just short on funds, payday loans online can offer a quick and convenient solution. In this guide, we’ll break down the best …

PeerGame Introduces Seamless Crypto Transactions with WalletConnect Integration

PeerGame Introduces Seamless Crypto Transactions with WalletConnect Integration

London, UK, May 06, 2025 (GLOBE NEWSWIRE) -- Leading cryptocurrency gaming company PeerGame has announced the launch of its new cashier system - its platform will now be integrated with WalletConnect for seamless, secure, and fast crypto transactions.  The …

Amerigo Announces Results of AGM

Amerigo Announces Results of AGM

VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; ARREF:OTC) (“Amerigo” or the “Company”) announces the results of voting at its 2025 Annual General Meeting of Shareholders (the “AGM”) held on May 5, 2025. A …

Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025

Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025

GAITHERSBURG, Md., May 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday, May 13, 2025. Altimmune management …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service